Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?
💡 What the odds say
Most likely: Cancer treatment at about a 65% chance — likely.
Data from Manifold’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
Loading…
How it resolves
Resolved by whoever created the market, at their discretion per the question's description. It's play-money (Mana) and not tied to an official source — treat it as a community forecast.
Resolution criteria
Resolution criteria: Approval from a recognized regulatory body, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or equivalent organizations in other countries. Categories: Targeting Viral Infections: This category encompasses the use of CRISPR technology to edit human cells in a way that makes them resistant to infections by specific viruses, such as HIV. Cancer treatment: Approval for therapies that use CRISPR to modify human cells to fight various forms of cancer, such as editing immune cells to target cancer cells more effectively. Anti-aging therapies: Approval for treatments aimed at delaying the aging process or reversing age-related deterioration at the genetic level. Enhancing human physical abilities: Approval for applications designed to enhance or improve human physical capabilities beyond the therapeutic treatment of disease, including but not limited to increased strength, endurance, or other physical traits. Date: The first regulatory approval must be documented on or before December 31, 2030
ⓘ A market settles under its own written rules, which can lag what looks decided in the news — so the price may not move to 100% the moment an outcome seems obvious.
View the official rules on Manifold ↗Related markets
Democratic Presidential Nominee 2028
The field is virtually nonexistent: only two candidates register at 1% each, and no one has broken 5%, making this the most open Democratic nomination race in modern history. The single biggest recent shift is the DNC's decision to put South Carolina first in the 2028 primary calendar (Axios, Jul 25), which could reshape candidate strategies and favor a different type of contender.
2 outcomes
Next General Election - Most Seats
The field is moderately concentrated with Labour leading at 36%, but Reform UK and Conservative are close; the biggest recent shift is Reform UK overtaking the Conservatives for second place, as seen in the stated odds, though no headline directly explains this.
9 outcomes
Republican Presidential Nominee 2028
The Republican nomination market is essentially a blank slate with no declared candidate, as the combined odds of the two listed figures (Byron Donalds at 1%, Mike Pence at 0%) barely exceed 1%, indicating the race is wide open for any major figure to enter and become the immediate front-runner.
2 outcomes
Democratic Presidential Nominee 2028
The field is moderately concentrated with Newsom and Ocasio-Cortez combining for 66%, but the 21% for both Buttigieg and Harris and a 23% 'Other' share show significant latent openness; the biggest recent shift is the DNC's decision to put South Carolina first in 2028 (NYT, Jul 24), which could reshape candidate strategies and delegate math.
8 outcomes